Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Complement C4d:EntNum:Pt:RBC:Qn

Known as: Complement C4d:Entitic Number:Point in time:Erythrocytes:Quantitative, fracción C4d del complemento:entítico:punto en el tiempo:eritrocitos:ordinal o cuantitativo:, Complément C4d:Nombre entitique:Temps ponctuel:GR:Quantitatif 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Coupling of two detectors is a powerful tool to enhance the overall analytical performance generating complementary information… Expand
Is this relevant?
2017
2017
Peritubular capillary C4d (ptc-C4d) usually marks active antibody-mediated rejection, while pseudolinear glomerular capillary C4d… Expand
  • figure 1
  • table 3
  • table 4
  • figure 3
  • figure 4
Is this relevant?
2017
2017
A new concept for rapid and efficient salt removal from minute volumes of saline samples is presented by using multiple phase… Expand
Is this relevant?
2013
2013
BACKGROUND Efforts to increase the specificity and sensitivity of human leukocyte antigen (HLA) antibody detection assays… Expand
Is this relevant?
2010
2010
BACKGROUND Recent studies indicate that not all low-level donor-specific human leukocyte antigen (HLA) antibodies (HLA-DSA) (i.e… Expand
Is this relevant?
2008
2008
BACKGROUND Renal biopsy is the gold standard for diagnosis of acute rejection in renal transplant recipients. The Banff (1997… Expand
Is this relevant?
2007
2007
AIMS To determine whether C4d immunopositivity helps recognition of humoral rejection in dysfunctional liver allografts… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
C4d staining of renal allografts is regarded as an in situ marker of active humoral rejection. Few data are available about the… Expand
Is this relevant?
2003
2003
To obtain further information about the cause for the rather large splitting of the C4 resonance line into the downfield (C4D… Expand
Is this relevant?
2002
2002
C4d-immunoreactive complement-activated oligodendrocytes (C4d-CAOs) have been described in several neurodegenerative diseases but… Expand
Is this relevant?